Author

Marco Cicardi

universit

Biography

Marco Cicardi  is currently working at Department of Biological and Clinical Sciences. Marco Cicardi  is research interests includes Pharmacy in Diagnosis .Marco Cicardi serving as an editorial member and reviewer of several international reputed journals. Marco Cicardi  has successfully completed his Administrative responsibilities. Marco Cicardi has authored of many research articles/books related to Medicine.
Title
Cited by
Year
The International/Canadian hereditary angioedema guideline
S Betschel, J Badiou, K Binkley, R Borici-Mazi, J Hébert, A Kanani, ...Allergy, Asthma & Clinical Immunology 15, 1-29, 2019201
150
2019
Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks
T Craig, B Zuraw, H Longhurst, M Cicardi, K Bork, C Grattan, C Katelaris, ...The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1793-1802. e2, 2019201
72
2019
International consensus on the use of genetics in the management of hereditary angioedema
AE Germenis, M Margaglione, JB Pesquero, H Farkas, S Cichon, D Csuka, ...The Journal of Allergy and Clinical Immunology: In Practice 8 (3), 901-911, 2020202
57
2020
ACE inhibitor-mediated angioedema
V Montinaro, M CicardiInternational Immunopharmacology 78, 106081, 2020202
56
2020
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
MA Riedl, M Maurer, JA Bernstein, A Banerji, HJ Longhurst, HH Li, P Lu, ...Allergy 75 (11), 2879-2887, 2020202
29
2020
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
A Banerji, JA Bernstein, DT Johnston, WR Lumry, M Magerl, M Maurer, ...Allergy 77 (3), 979-990, 2022202
28
2022
Impaired control of the contact system in hereditary angioedema with normal C1‐inhibitor
M Bova, C Suffritti, V Bafunno, S Loffredo, G Cordisco, S Del Giacco, ...Allergy 75 (6), 1394-1403, 2020202
27
2020
Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
WR Lumry, K Weller, M Magerl, A Banerji, HJ Longhurst, MA Riedl, ...Allergy 76 (4), 1188-1198, 2021202
26
2021
Opioid utilization and perception of pain control in hospitalized patients: a cross‐sectional study of 11 sites in 8 countries
M Burden, A Keniston, MA Wallace, JW Busse, J Casademont, ...Journal of Hospital Medicine 14 (12), 737-745, 2019201
25
2019
Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course
R Castelli, G Lambertenghi Delilliers, A Gidaro, M Cicardi, ...Clinical & Experimental Immunology 201 (3), 258-265, 2020202
22
2020
The central role of endothelium in hereditary angioedema due to C1 inhibitor deficiency
MA Wu, M Bova, S Berra, R Senter, D Parolin, S Caccia, M CicardiInternational Immunopharmacology 82, 106304, 2020202
19
2020
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
DS Levy, H Farkas, MA Riedl, FI Hsu, JP Brooks, M Cicardi, ...Allergy, Asthma & Clinical Immunology 16, 1-9, 2020202
18
2020
Handling shock in idiopathic systemic capillary leak syndrome (Clarkson’s disease): less is more
MA Wu, R Colombo, GM Podda, M CicardiInternal and emergency medicine 14, 723-730, 2019201
15
2019
Driving towards Precision Medicine for angioedema without wheals
AE Germenis, M CicardiJournal of Autoimmunity 104, 102312, 2019201
15
2019
Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene
I Guryanova, C Suffritti, D Parolin, A Zanichelli, N Ishchanka, E Polyakova, ...Clinical and Molecular Allergy 19 (1), 1-8, 2021202
13
2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings …
WR Lumry, B Zuraw, M Cicardi, T Craig, J Anderson, A Banerji, ...Orphanet journal of rare diseases 16, 1-14, 2021202
13
2021
Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: an observational study
A Zanichelli, M Ghezzi, I Santicchia, R Vacchini, M Cicardi, A Sparaco, ...PLoS One 15 (3), e02308, 2020202
12
2020
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study
HH Li, B Zuraw, HJ Longhurst, M Cicardi, K Bork, J Baker, W Lumry, ...Allergy, Asthma & Clinical Immunology 15, 1-8, 2019201
12
2019
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings
T Craig, W Lumry, M Cicardi, B Zuraw, JA Bernstein, J Anderson, J Jacobs, ...The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 2035-2038, 2019201
11
2019
Long-term efficacy of subcutaneous C1 inhibitor in pediatric patients with hereditary angioedema
D Levy, T Caballero, I Hussain, A Reshef, J Anderson, J Baker, ...Pediatric allergy, immunology, and pulmonology 33 (3), 136-141, 2020202
8
2020

Referred From: https://scholar.google.com/citations?hl=en&user=KUZ3yooAAAAJ

Cited by
Citations 21892
h-index 79
i10-index 204
Recommended Journals
Open Access Journals